Any feedback?
Please rate this page
(all_enzymes.php)
(0/150)

BRENDA support

2.4.1.313: protein O-mannose beta-1,3-N-acetylgalactosaminyltransferase

This is an abbreviated version!
For detailed information about protein O-mannose beta-1,3-N-acetylgalactosaminyltransferase, go to the full flat file.

Word Map on EC 2.4.1.313

Reaction

UDP-N-acetyl-alpha-D-galactosamine
+
3-O-[N-acetyl-beta-D-glucosaminyl-(1->4)-alpha-D-mannosyl]-L-threonyl-[protein]
=
UDP
+
3-O-[N-acetyl-beta-D-galactosaminyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->4)-alpha-D-mannosyl]-L-threonyl-[protein]

Synonyms

B3GALNT2, B3GalTN2, beta 1,3-N-acetylgalactosaminyltransferase2, beta-1,3-N-acetylgalactosaminyltransferase 2, beta1,3-N-acetylgalactosaminyltransferase II, beta1,3-N-acetylgalactosaminyltransferase-II, beta3GalNAc-T2, UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2

ECTree

     2 Transferases
         2.4 Glycosyltransferases
             2.4.1 Hexosyltransferases
                2.4.1.313 protein O-mannose beta-1,3-N-acetylgalactosaminyltransferase

Disease

Disease on EC 2.4.1.313 - protein O-mannose beta-1,3-N-acetylgalactosaminyltransferase

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Breast Neoplasms
Involvement of B3GALNT2 overexpression in the cell growth of breast cancer.
Carcinoma, Hepatocellular
Increased B3GALNT2 in hepatocellular carcinoma promotes macrophage recruitment via reducing acetoacetate secretion and elevating MIF activity.
Hydrocephalus
A nonsense mutation in B3GALNT2 is concordant with hydrocephalus in Friesian horses.
Congenital hydrocephalus in a Belgian draft horse associated with a nonsense mutation in B3GALNT2.
Intellectual Disability
B3GALNT2 mutations associated with non-syndromic autosomal recessive intellectual disability reveal a lack of genotype-phenotype associations in the muscular dystrophy-dystroglycanopathies.
Muscular Dystrophies
B3GALNT2 is a gene associated with congenital muscular dystrophy with brain malformations.
B3GALNT2-Related Dystroglycanopathy: Expansion of the Phenotype with Novel Mutation Associated with Muscle-Eye-Brain Disease, Walker-Warburg Syndrome, Epileptic Encephalopathy-West Syndrome, and Sensorineural Hearing Loss.
Integrative data mining highlights candidate genes for monogenic myopathies.
Mutations in B3GALNT2 Cause Congenital Muscular Dystrophy and Hypoglycosylation of ?-Dystroglycan.
Serial prenatal and postnatal MRI of dystroglycanopathy in a patient with familial B3GALNT2 mutation.
SGK196 is a glycosylation-specific O-mannose kinase required for dystroglycan function.
Neoplasms
Increased B3GALNT2 in hepatocellular carcinoma promotes macrophage recruitment via reducing acetoacetate secretion and elevating MIF activity.
Seizures
B3GALNT2 mutations associated with non-syndromic autosomal recessive intellectual disability reveal a lack of genotype-phenotype associations in the muscular dystrophy-dystroglycanopathies.